AAAAAA
Results: 1-25/56
Authors:
Parving, HH
Hovind, P
Rossing, K
Andersen, S
Citation: Hh. Parving et al., Evolving strategies for renoprotection: diabetic nephropathy, CURR OP NEP, 10(4), 2001, pp. 515-522
Authors:
Tarnow, L
Grarup, N
Hansen, T
Parving, HH
Pedersen, O
Citation: L. Tarnow et al., Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients, NEPH DIAL T, 16(8), 2001, pp. 1653-1656
Authors:
Christensen, PK
Larsen, S
Horn, T
Olsen, S
Parving, HH
Citation: Pk. Christensen et al., Renal function and structure in albuminuric type 2 diabetic patients without retinopathy, NEPH DIAL T, 16(12), 2001, pp. 2337-2347
Authors:
Gaede, P
Vedel, P
Parving, HH
Pedersen, O
Citation: P. Gaede et al., Elevated levels of plasma von Willebrand factor and the risk of macro- andmicrovascular disease in type 2 diabetic patients with microalbuminuria, NEPH DIAL T, 16(10), 2001, pp. 2028-2033
Authors:
Parving, HH
Citation: Hh. Parving, Hypertension and diabetes: the scope of the problem, BLOOD PRESS, 10, 2001, pp. 25-31
Authors:
Gaede, P
Poulsen, HE
Parving, HH
Pedersen, O
Citation: P. Gaede et al., Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients, DIABET MED, 18(9), 2001, pp. 756-760
Authors:
Rossing, P
Breum, L
Major-Pedersen, A
Sato, A
Winding, H
Pietersen, A
Kastrup, J
Parving, HH
Citation: P. Rossing et al., Prolonged QTc interval predicts mortality in patients with Type 1 diabetesmellitus, DIABET MED, 18(3), 2001, pp. 199-205
Authors:
Hovind, P
Tarnow, L
Rossing, P
Teerlink, T
Stehouwer, CDA
Emeis, JJ
Parving, HH
Citation: P. Hovind et al., Progression of diabetic nephropathy: Role of plasma homocysteine and plasminogen activator inhibitor-1, AM J KIDNEY, 38(6), 2001, pp. 1376-1380
Authors:
Hovind, P
Rossing, P
Tarnow, L
Toft, H
Parving, J
Parving, HH
Citation: P. Hovind et al., Remission of nephrotic-range albuminuria in type 1 diabetic patients, DIABET CARE, 24(11), 2001, pp. 1972-1977
Authors:
Parving, HH
Rossing, P
Citation: Hh. Parving et P. Rossing, Therapeutic benefits of ACE inhibitors and other antihypertensive drugs inpatients with type 2 diabetes, DIABET CARE, 24(1), 2001, pp. 177-178
Authors:
Parving, HH
Harrington, JT
Lewis, J
Boner, G
Lewis, EJ
Viberti, G
Gilbert, R
Raz, I
Cooper, M
Rossing, K
Citation: Hh. Parving et al., Diabetic nephropathy: Prevention and treatment, KIDNEY INT, 60(5), 2001, pp. 2041-2055
Authors:
Christensen, PK
Lund, S
Parving, HH
Citation: Pk. Christensen et al., Autoregulated glomerular filtration rate during candesartan treatment in hypertensive type 2 diabetic patients, KIDNEY INT, 60(4), 2001, pp. 1435-1442
Authors:
Parving, HH
Hommel, E
Jensen, BR
Hansen, HP
Citation: Hh. Parving et al., Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients, KIDNEY INT, 60(1), 2001, pp. 228-234
Authors:
Hovind, P
Rossing, P
Tarnow, L
Smidt, UM
Parving, HH
Citation: P. Hovind et al., Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively, KIDNEY INT, 60(1), 2001, pp. 277-283
Authors:
Hovind, P
Rossing, P
Tarnow, L
Smidt, UM
Parving, HH
Citation: P. Hovind et al., Progression of diabetic nephropathy, KIDNEY INT, 59(2), 2001, pp. 702-709
Authors:
Hansen, HP
Lund, SS
Rossing, P
Tarnow, L
Nielsen, FS
Jensen, T
Parving, HH
Citation: Hp. Hansen et al., Preventing diabetic nephropathy: an audit, SC J CL INV, 61(6), 2001, pp. 471-477
Authors:
Myrup, B
Rossing, P
Jensen, T
Parving, HH
Holmer, G
Gram, J
Kluft, C
Jespersen, J
Citation: B. Myrup et al., Lack of effect of fish oil supplementation on coagulation and transcapillary escape rate of albumin in insulin-dependent diabetic patients with diabetic nephropathy, SC J CL INV, 61(5), 2001, pp. 349-356
Authors:
Christensen, PK
Lund, S
Parving, HH
Citation: Pk. Christensen et al., The impact of glycaemic control on autoregulation of glomerular filtrationrate in patients with non-insulin dependent diabetes, SC J CL INV, 61(1), 2001, pp. 43-50
Authors:
Brenner, BM
Cooper, ME
de Zeeuw, D
Keane, WF
Mitch, WE
Parving, HH
Remuzzi, G
Snapinn, SM
Zhang, ZX
Shahinfar, S
Citation: Bm. Brenner et al., Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy, N ENG J MED, 345(12), 2001, pp. 861-869
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes
Authors:
Parving, HH
Lehnert, H
Brochner-Mortensen, J
Gomis, R
Andersen, S
Arner, P
Citation: Hh. Parving et al., The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes, N ENG J MED, 345(12), 2001, pp. 870-878
Authors:
Poirier, O
Nicaud, V
Vionnet, N
Raoux, S
Tarnow, L
Vlassara, H
Parving, HH
Cambien, F
Citation: O. Poirier et al., Polymorphism screening of four genes encoding advanced glycation end-product putative receptors - Association study with nephropathy in type 1 diabetic patients, DIABETES, 50(5), 2001, pp. 1214-1218
Authors:
Tarnow, L
Stehouwer, CDA
Emeis, JJ
Poirier, O
Cambien, F
Hansen, BV
Parving, HH
Citation: L. Tarnow et al., Plasminogen activator inhibitor-1 and apolipoprotein E gene polymorphisms and diabetic angiopathy, NEPH DIAL T, 15(5), 2000, pp. 625-630
Authors:
Clausen, P
Jacobsen, P
Rossing, K
Jensen, JS
Parving, HH
Feldt-Rasmussen, B
Citation: P. Clausen et al., Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy, DIABET MED, 17(9), 2000, pp. 644-649
Authors:
Andersen, S
Schalkwijk, CG
Stehouwer, CDA
Parving, HH
Citation: S. Andersen et al., Angiotensin II blockade is associated with decreased plasma leukocyte adhesion molecule levels in diabetic nephropathy, DIABET CARE, 23(7), 2000, pp. 1031-1032
Authors:
Johannesen, J
Tarnow, L
Parving, HH
Nerup, J
Pociot, F
Citation: J. Johannesen et al., CCTTT-repeat polymorphism in the human NOS2-promoter confers low risk of diabetic nephropathy in type 1 diabetic patients, DIABET CARE, 23(4), 2000, pp. 560-562